surf break copy_edited.jpg

How Innovation Can Empower Patients and their Families

Have you ever wondered if a past event could have turned out differently if you had additional knowledge, experience or tools?

This is what Phil Martie, founder of Nicolette, contemplated after parenting premature twins requiring neonatal care. Phil’s newborn son and daughter, Bexley and Nicolette, were immediately admitted into a Neonatal Intensive Care Unit (NICU). After 27 days in the NICU at a local community hospital, Phil and his wife decided to transfer their infants to CHOC. Unfortunately, Nicolette passed away on the day of her transfer, however, Bexley made it through a total of 110 days in a NICU and has grown into a healthy six-year-old.


Recent Posts

See All

Emerging Opportunities: Real-World Evidence

Key takeaways • Real-world evidence (RWE) has the potential to be useful across the entire healthcare ecosystem, including for clinical trials, care provision, determining treatment outcomes, and post

Invitae to Acquire Ciitizens

Invitae (NYSE: NVTA), a leading medical genetics company, today announced it has entered into a definitive agreement to acquire Ciitizen, a patient-centric consumer health tech company. Backed by a16z